Cabaletta Bio, Inc. — Director's Dealing 2019

Oct 25, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2019-10-24

Reporting Person: Chang David J. (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$6.30	2029-06-23	Common Stock (185709)		Direct

Footnotes

F1: This option vests over four years, with 25% vesting on June 17, 2020, and the remaining shares vesting in 12 equal quarterly installments thereafter.